±è¹Ì¼±
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ½ÖÅÂÀÓ½Å, ¿¹ºñÀӽźκÎ, ÁÖ»ê±âÇÐ, Á¤¹ÐÃÊÀ½ÆÄ, ÀϹݺÎÀΰú, ÅÂ¾Æ °Ë»ç ¹× Áø´Ü, °íÀ§ÇèÀÓ½Å
Á÷
ˤ
: Á¶±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
6
±¹³»
Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patient : ´ëÇÑ»êºÎÀΰúÇÐȸÁö 2015
5
±¹³»
The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse : ´ëÇÑ»êºÎÀΰúÇÐȸÁö 2016
4
ÇØ¿Ü
Endometrioid adenocarcinoma arising from endometriosis of the pelvic peritoneum mimicking advanced ovarian cancer: A case report. : Journal of obstetrics and gynaecology 2017
3
±¹³»
Clinical significance of sonographic soft markers: A review : Journal of Genetic Medicine 2018
2
ÇØ¿Ü
Transabdominal selective feticide in dichorionic twins: Ten years¡¯ experience at a single center : The Journal of Obstetrics and Gynaecology Research 2018
1
ÇØ¿Ü
Procedural and obstetrical outcomes after embryo reduction or fetal reduction in multifetal pregnancies: a retrospective study : Ultrasound in obstetrics and gynecology 2018
1
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729